XOMA Royalty (XOMA) Cash from Operations (QoQ) (2010 - 2026)
XOMA Royalty (XOMA) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.27% |
| Jun 30, 2025 | 194.36% |
| Mar 31, 2025 | 175.71% |
| Dec 31, 2024 | 66.34% |
| Sep 30, 2024 | -416.28% |
| Jun 30, 2024 | 155.12% |
| Mar 31, 2024 | -25.97% |
| Dec 31, 2023 | -87.09% |
| Sep 30, 2023 | 70.88% |
| Jun 30, 2023 | -46.39% |
| Mar 31, 2023 | -26.58% |
| Dec 31, 2022 | -6.20% |
| Sep 30, 2022 | 15.15% |
| Jun 30, 2022 | -327.85% |
| Mar 31, 2022 | -103.29% |
| Dec 31, 2021 | 1,096.49% |
| Sep 30, 2021 | 22.64% |
| Jun 30, 2021 | -334.90% |
| Mar 31, 2021 | -105.17% |
| Dec 31, 2020 | 825.70% |